RxDoctor Payments Data

Scott Winston

Family Medicine · Sheridan, ARNPI 1184690455

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Novo Nordisk at 28.6% of the total. Reporting peaked in 2021 at $368 and has fallen 93.9% since, to $22 in 2024.

$1,325in general payments, 2019–2025

Across 96 payments — averaging $13.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$378
  • Pfizer$216
  • GSK$130
  • AbbVie$72
  • Takeda Pharmaceuticals U.S.A., Inc.$63
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$53
  • plus $412 from 15 others

What the payments were for

  • Food & beverage$1,325100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,325 in reported general payments places this provider in the 60th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas →

Other family medicine in Sheridan

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →